Title: |
252Cf-Based Neutron Brachytherapy (NBT) as a High-LET Radiotherapy |
|
Speaker: |
Dr. Chris Wang |
|
Affiliation: |
GT-NRE/MP Programs |
|
When: |
Thursday, April 22, 2010 at 11:00:00 AM |
|
Where: |
Boggs Building, Room 3-47, 3rd FL |
|
Host: |
Farzad Rahnema | |
Abstract The 252Cf-Based Neutron Brachytherapy (NBT) is a high-LET radiotherapy. It has been demonstrated for over two decades that the NBT is more effective in treating radioresistant tumors. Today, however, the NBT is still not widely used. Its far more expensive counter part, the heavy ion therapy, on the other hand, has received much attention worldwide lately. In this seminar, I will discuss the current status of the NBT and present some of the research recently performed at Georgia Tech. |
||
Biography Dr. C-K Chris Wang has more than thirty years of combined industry and academic experience in nuclear engineering, radiation health physics, medical physics, and radiation biology. He has been in the last 19 years a faculty member, and is currently professor at the Nuclear & Radiological Engineering and Medical Physics Program at the Georgia Institute of Technology. His areas of expertise include radiation detection, dosimetry, micro- and nano-dosimetry, radiobiological modeling in radiotherapy, and neutron-based radiotherapy modalities for cancer treatment. |
||
Notes |
Refreshments will be served. |